JW Lifescience Corporation
Research JW Lifescience Corporation (234080.KS) on Bullrun: market cap KRW 163.52B, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker234080.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 163.52B
- Dividend yield5.1%
- Financial periodQ2 2026
- RevenueKRW 63.25B
- Net incomeKRW 8.01B
- Free cash flowKRW 15.81B
- Gross margin28.1%
Valuation Snapshot
latest market cap is KRW 163.52B; dividend yield is 5.1%.
Peer valuation comparison
Latest dividend yield is 5.14% versus a Healthcare sector median of 2.4% (114.2% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 163.52B | n/a | 5.2% | 550 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 550 KRW, yield 5.1%.
About JW Lifescience Corporation
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011.
ETFs that hold JW Lifescience Corporation
US-listed ETFs
JW Lifescience Corporation is held by 6 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
| Dimensional World ex U.S. Core Equity 2 ETF (DFAX) | <0.01% | 0.28% |
| Dimensional Emerging Markets Value ETF (DFEV) | <0.01% | 0.43% |
| Dimensional Emerging Markets ex China Core Equity ETF (DEXC) | <0.01% | 0.43% |
| Dimensional Emerging Markets Sustainability Core 1 ETF (DFSE) | <0.01% | 0.41% |
Portfolios as filed with the SEC on Form N-PORT, dated July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is JW Lifescience Corporation's market cap?
JW Lifescience Corporation's market capitalization is KRW 163.52B.
Does JW Lifescience Corporation pay a dividend?
JW Lifescience Corporation has a dividend yield of 5.1%.
What does JW Lifescience Corporation do?
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea.